Worldwide, there is growing concern about the burden of pneumonia. Severe community-acquired pneumonia (CAP) is frequently complicated by pulmonary and extra-pulmonary complications, including sepsis, septic shock, acute respiratory distress syndrome, and acute cardiac events, resulting in significantly increased intensive care admission rates and mortality rates. Streptococcus pneumoniae (Pneumococcus) remains the most common causative pathogen in CAP. However, several bacteria and respiratory viruses are responsible, and approximately 6% of cases are due to the so-called PES (Pseudomonas aeruginosa, extended-spectrum β-lactamase Enterobacteriaceae, and methicillin-resistant Staphylococcus aureus) pathogens. Of these, P. aeruginosa and met...
Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to the an...
Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to the an...
Pseudornonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to the a...
Worldwide, there is growing concern about the burden of pneumonia. Severe community-acquired pneumon...
Worldwide, there is growing concern about the burden of pneumonia. Severe community-acquired pneumon...
AbstractRationaleThe new acronym, PES pathogens (Pseudomonas aeruginosa, Enterobacteriaceae extended...
Community-acquired pneumonia (CAP) is the leading cause of death among infectious diseases and an im...
Background: Pseudomonas aeruginosa is not a frequent pathogen in community-acquired pneumonia (CAP)....
Antimicrobial therapy is the mainstay of management for community-acquired pneumonia (CAP). Accordin...
Community-acquired pneumonia (CAP) has an annual incidence of 2 to 10‰ that increases with advancing...
Community-acquired pneumonia (CAP) is a common infectious disease in the United States and the incid...
Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic antibiotic resistanc...
Community acquired pneumonia (CAP) is a major cause of morbidity and mortality worldwide. The contri...
AbstractOf 259 patients admitted to an intensive care unit with severe acute community-acquired pneu...
Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to the an...
Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to the an...
Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to the an...
Pseudornonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to the a...
Worldwide, there is growing concern about the burden of pneumonia. Severe community-acquired pneumon...
Worldwide, there is growing concern about the burden of pneumonia. Severe community-acquired pneumon...
AbstractRationaleThe new acronym, PES pathogens (Pseudomonas aeruginosa, Enterobacteriaceae extended...
Community-acquired pneumonia (CAP) is the leading cause of death among infectious diseases and an im...
Background: Pseudomonas aeruginosa is not a frequent pathogen in community-acquired pneumonia (CAP)....
Antimicrobial therapy is the mainstay of management for community-acquired pneumonia (CAP). Accordin...
Community-acquired pneumonia (CAP) has an annual incidence of 2 to 10‰ that increases with advancing...
Community-acquired pneumonia (CAP) is a common infectious disease in the United States and the incid...
Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic antibiotic resistanc...
Community acquired pneumonia (CAP) is a major cause of morbidity and mortality worldwide. The contri...
AbstractOf 259 patients admitted to an intensive care unit with severe acute community-acquired pneu...
Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to the an...
Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to the an...
Pseudomonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to the an...
Pseudornonas aeruginosa is a challenging bacterium to treat due to its intrinsic resistance to the a...